Monitor for actual execution of the 144 notice in subsequent Form 4 filings. A completed sale of this magnitude by the chairman could signal reduced insider conviction and may pressure the stock near-term. Watch for any concurrent open-market purchases by other insiders or the company's buyback activity as a counter-signal.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 28 $570.97entry
- T+1 · 4mo ago +2.44%α +3.98% · $584.93
- T+5 · 4mo ago +0.41%α −1.86% · $573.29
- T+20 · 3mo ago +7.55%α +4.17% · $614.06
- T+60 · 27d ago +16.03%α +11.68% · $662.48
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Chairman August J. Troendle filed a Form 144 notice of intent to sell 307,959 shares of Medpace common stock, valued at approximately $184.8 million based on the filing date. This represents a substantial proposed sale by the company's founder and chairman, signaling potential insider distribution at a $17.2B market cap company. The filing is an advance notice of intent, not a completed sale, but the magnitude relative to market cap (~1.1%) and the insider's role make it a notable event for traders to monitor for execution.
Key Facts
- Chairman August J. Troendle filed Form 144 to sell 307,959 shares
- Estimated value of proposed sale: ~$184.8 million
- Shares acquired via NQ stock options exercised on 03/07/2025
- Sale is to be executed through UBS Financial Services Inc
- Troendle is also trustee of The August J. Troendle Revocable Trust
Financial Impact
Proposed sale of 307,959 shares valued at ~$184.8 million, representing ~1.1% of Medpace's $17.2B market cap
Risk Factors
- Form 144 is an intent to sell, the sale may not be executed or may be modified
- Large insider sale could be for personal diversification or tax planning, not a negative signal about company fundamentals
- CRO sector fundamentals remain strong; this is an insider-specific event
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001969223-26-000803 |
| Document: 0001969223-26-000803-index.html | 0001969223-26-000803 |
| Document: 0001969223-26-000803.txt | 0001969223-26-000803 |
Track record
24 reports on MEDP
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers